解锁免疫系统:对肺癌的下一代免疫疗法的进展
Furqan Choudhary1, Aman Safdar1, M Z Abdin1
1Department of Biotechnology, Jamia Hamdard, New Delhi, India.
Mini reviews in medicinal chemistry
|October 31, 2025
概括
肺癌治疗的进步,包括免疫检查点抑制剂和纳米技术,提供了新的希望. 个性化医学和人工智能是克服抵抗和改善患者治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 纳米技术 纳米技术
背景情况:
- 由于分子异质性和免疫抑制瘤微环境,肺癌是癌症死亡的主要原因.
- 现有的治疗方法面临抗药性挑战,需要新的治疗策略.
研究的目的:
- 审查肺癌治疗的最新进展,重点关注免疫检查点抑制剂 (ICI) 和新型药物输送系统.
- 突出预测生物标志物和人工智能等新兴技术在个性化肺癌管理中的作用.
主要方法:
- 对涉及免疫检查点抑制剂 (例如,尼沃卢马布,布利祖马布,杜尔瓦卢马布) 和双特异组合的临床试验的审查.
- 探索纳米技术应用 (例如,聚合物纳米颗粒,智能水凝) 用于向药物输送.
- 预测生物标志物的分析 (PD-L1,TMB,ctDNA,放射学) 用于患者选择和反应评估.
主要成果:
- 针对PD-1,PD-L1和CTLA-4的ICI代表了治疗非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的重大进展.
- 纳米技术可以实现向药物输送,增加局部度并降低系统毒性.
- 预测生物标志物对于实时患者选择和治疗反应监测至关重要.
结论:
- 尽管取得了进展,但免疫疗法耐药性和免疫相关不良事件 (irAEs) 等挑战仍然存在.
- 新型生物标志物,精密技术和人工智能的整合对于克服耐药性和优化个性化肺癌护理至关重要.
- 持续的研究对于开发有效的组合疗法和个性化治疗策略至关重要,以提高生存率和患者体验.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


